Cargando…
Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells
The most conserved molecular phenotype of Fragile X Syndrome (FXS) is aberrant protein synthesis. This has been validated in a variety of experimental model systems from zebrafish to rats, patient-derived lymphoblasts and fibroblasts. With the advent of personalized medicine paradigms, patient-deriv...
Autores principales: | Pal, Rakhi, Bhattacharya, Aditi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468675/ https://www.ncbi.nlm.nih.gov/pubmed/30862080 http://dx.doi.org/10.3390/brainsci9030059 |
Ejemplares similares
-
Molecular Biomarkers in Fragile X Syndrome
por: Zafarullah, Marwa, et al.
Publicado: (2019) -
Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome
por: Jasoliya, Mittal, et al.
Publicado: (2020) -
Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017) -
Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome
por: Berman, Robert F, et al.
Publicado: (2014) -
Fragile X Syndrome
por: Saldarriaga, Wilmar, et al.
Publicado: (2014)